140 related articles for article (PubMed ID: 11334468)
21. Immunohistochemical expression of podoplanin (D2-40), lymphangiogenesis, and neoangiogenesis in tooth germ, ameloblastomas, and ameloblastic carcinomas.
Sánchez-Romero C; Bologna-Molina R; Mosqueda-Taylor A; de Almeida OP
J Oral Pathol Med; 2017 Sep; 46(8):618-624. PubMed ID: 27859616
[TBL] [Abstract][Full Text] [Related]
22. Expression of bone morphogenetic proteins and their associated molecules in ameloblastomas and adenomatoid odontogenic tumors.
Kumamoto H; Ooya K
Oral Dis; 2006 Mar; 12(2):163-70. PubMed ID: 16476038
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas.
Kumamoto H; Yamauchi K; Yoshida M; Ooya K
J Oral Pathol Med; 2003 Feb; 32(2):114-20. PubMed ID: 12542835
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical detection of retinoblastoma protein and E2 promoter-binding factor-1 in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2006 Mar; 35(3):183-9. PubMed ID: 16454815
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical detection of phosphorylated Akt, PI3K, and PTEN in ameloblastic tumors.
Kumamoto H; Ooya K
Oral Dis; 2007 Sep; 13(5):461-7. PubMed ID: 17714348
[TBL] [Abstract][Full Text] [Related]
26. Association between vascular endothelial growth factor (VEGF) expression and tumor angiogenesis in ameloblastomas.
Kumamoto H; Ohki K; Ooya K
J Oral Pathol Med; 2002 Jan; 31(1):28-34. PubMed ID: 11896820
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical detection of platelet-derived endothelial cell growth factor/thymidine phosphorylase and angiopoietins in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2006 Nov; 35(10):606-12. PubMed ID: 17032393
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical detection of MT1-MMP, RECK, and EMMPRIN in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2006 Jul; 35(6):345-51. PubMed ID: 16762015
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical detection of BH3-only proteins in ameloblastic tumors.
Kumamoto H; Ooya K
Oral Dis; 2008 Sep; 14(6):550-5. PubMed ID: 18826384
[TBL] [Abstract][Full Text] [Related]
30. Expression of E-cadherin and alpha-catenin in epithelial odontogenic tumors: an immunohistochemical study.
Kumamoto H; Ooya K
J Oral Pathol Med; 1999 Apr; 28(4):152-7. PubMed ID: 10235367
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor.
Krishna A; Kaveri H; Naveen Kumar RK; Kumaraswamy KL; Shylaja S; Murthy S
J Cancer Res Ther; 2012; 8(2):232-7. PubMed ID: 22842367
[TBL] [Abstract][Full Text] [Related]
32. Expression of laminin-5 in ameloblastomas and human fetal teeth.
Salo T; Kainulainen T; Parikka M; Heikinheimo K
J Oral Pathol Med; 1999 Sep; 28(8):337-42. PubMed ID: 10478957
[TBL] [Abstract][Full Text] [Related]
33. Expression of the stem cell marker, SOX2, in ameloblastoma and dental epithelium.
Juuri E; Isaksson S; Jussila M; Heikinheimo K; Thesleff I
Eur J Oral Sci; 2013 Dec; 121(6):509-16. PubMed ID: 24148099
[TBL] [Abstract][Full Text] [Related]
34. Detection of apoptosis-related factors and apoptotic cells in ameloblastomas: analysis by immunohistochemistry and an in situ DNA nick end-labelling method.
Kumamoto H
J Oral Pathol Med; 1997 Oct; 26(9):419-25. PubMed ID: 9385580
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical detection of uPA, uPAR, PAI-1, and maspin in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2007 Sep; 36(8):488-94. PubMed ID: 17686008
[TBL] [Abstract][Full Text] [Related]
36. Is podoplanin expression associated with the proliferative activity of ameloblastomas?
Tjioe KC; Oliveira DT; Soares CT; Lauris JR; Damante JH
Oral Dis; 2012 Oct; 18(7):673-9. PubMed ID: 22443371
[TBL] [Abstract][Full Text] [Related]
37. Nuclear localization of epidermal growth factor receptor (EGFR) in ameloblastomas.
Pereira NB; do Carmo AC; Diniz MG; Gomez RS; Gomes DA; Gomes CC
Oncotarget; 2015; 6(12):9679-85. PubMed ID: 25991665
[TBL] [Abstract][Full Text] [Related]
38. Cytoskeletal gene expression in normal and neoplastic human odontogenic epithelia.
Heikinheimo K; Sandberg M; Happonen RP; Virtanen I; Bosch FX
Lab Invest; 1991 Dec; 65(6):688-701. PubMed ID: 1721670
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical expression of p53, p21/waf1, rb, p16, cyclin D1, p27, Ki67, cyclin A, cyclin B1, bcl2, bax and bak proteins and apoptotic index in normal thymus.
Kanavaros P; Stefanaki K; Rontogianni D; Papalazarou D; Sgantzos M; Arvanitis D; Vamvouka C; Gorgoulis V; Siatitsas I; Agnantis NJ; Bai M
Histol Histopathol; 2001 Oct; 16(4):1005-12. PubMed ID: 11642719
[TBL] [Abstract][Full Text] [Related]
40. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
